In summary, NRIP's interactions with various proteins such as AChR, calmodulin, and α-actinin 2 influence diverse muscle functions and retrogradely control motor neuron growth, all of which may contribute to the therapeutic efficacy of AAV-NRIP gene therapy in ALS mouse models. The gene discussed is DCAF6; the disease is amyotrophic lateral sclerosis.